September 2015. Volume 11. Number 3

¿El uso del propranolol acelera la resolución de los hemangiomas infantiles?

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

EP | Evidentia Praxis

Authors: Albi Rodríguez MS1, Ruiz-Canela Cáceres J2.
1Servicio de Neumología Pediátrica. Hospital Universitario 12 de Octubre. Madrid. España.
2CS Virgen de África. Sevilla. España.
Correspondence: María Salomé Albi Rodríguez. Email: msalbir@gmail.com
Reception date: 29/08/2015
Acceptance date: 04/09/2015
Publication date: 09/09/2015

Abstract

How to cite this article

Albi Rodríguez MA, Ruiz-Canela Cáceres J. ¿El uso del propranolol acelera la resolución de los hemangiomas infantiles? Evid Pediatr. 2015;11:38.

EP | Evidentia Praxis

Authors: Albi Rodríguez MS1, Ruiz-Canela Cáceres J2.
1Servicio de Neumología Pediátrica. Hospital Universitario 12 de Octubre. Madrid. España.
2CS Virgen de África. Sevilla. España.
Correspondence: María Salomé Albi Rodríguez. Email: msalbir@gmail.com
Reception date: 29/08/2015
Acceptance date: 04/09/2015
Publication date: 09/09/2015

Sorry, there is no English version for this item.

How to cite this article

Albi Rodríguez MA, Ruiz-Canela Cáceres J. ¿El uso del propranolol acelera la resolución de los hemangiomas infantiles? Evid Pediatr. 2015;11:38.

References

  1. Leonardi-Bee J, Batta K, O’Brien C, Bath-Hextall FJ. Interventions for infantile haemangiomas (strawberry birthmarks) of the skin. Cochrane Database Syst Rev. 2011 May 11;(5):CD006545.
  2. Manual Cochrane de Revisiones Sistemáticas de Intervenciones. En: Cochrane Iberoamérica [en línea] [consultado el 04/09/2015]. Disponible en: http://es.cochrane.org/sites/es.cochrane.org/files/uploads/Manual_Cochrane_510_reduit.pdf
  3. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ, et al. Going from evidence to recommendations. BMJ. 2008;336:1049-51.
  4. Leaute-Labreze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372:735-46.
  5. Hogeling M, Adams S, Wargon O. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics. 2011;128:e259-66.
  6. Leaute-Labreze C, Dumas de la Roque E, Nacka F, Abouelfath A, Grenier N, Rebola M, et al. Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants < 4 months of age. Br J Dermatol. 2013;169:181-3.
  7. Bauman NM, McCarter RJ, Guzzetta PC, Shin JJ, Oh AK, Preciado DA, et al. Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2014;140:323-30.
  8. Malik MA, Menon P, Rao KLN, Samujh R. Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study. J Pediatr Surg. 2013;48:2453-9.
  9. Hoeger PH, Harper JI, Baselga E, Bonnet D, Boon LM, Atti MCD, et al. Treatment of infantile haemangiomas: recommendations of a European expert group. Eur J Pediatr. 2015;174:855-65.
  10. Marqueling AL, Oza V, Frieden IJ, Puttgen KB. Propranolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol. 2013;30:182-91.
  11. Izadpanah A, Izadpanah A, Kanevsky J, Belzile E, Schwarz K. Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta-analysis. Plast Reconstr Surg. 2013;131:601-13.
  12. Dalby TK, Lester-Smith D. Propranolol for the treatment of infantile haemangioma. J Paediatr Child Health. 2013;49:148-51.
09/09/2015

Linked Comment